STRATTON MANAGEMENT CO - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.

Quarter-by-quarter ownership
STRATTON MANAGEMENT CO ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2014$303,000
-4.1%
2,4000.0%0.01%
-13.3%
Q1 2014$316,000
+12.1%
2,4000.0%0.02%
+15.4%
Q4 2013$282,000
+12.8%
2,4000.0%0.01%0.0%
Q3 2013$250,0002,4000.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2014
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders